Scientific Concept of the National Cohort (status ... - Nationale Kohorte

293
References
102. Fairbanks, V., et al., Modern nutrition in health and disease. Lea and Febiger,
Philadelphia, PA, 1988: p. 193-226.
103. Brock, J., Iron in infection, immunity, inflammation and neoplasia. Iron metabolism
in health and disease, 1994: p. 353–372.
104. Kemper, C.J., M. Ziegler, and S. Taylor, Überprüfung der psychometrischen
Qualität der deutschen Version des Angstsensitivitätsindex-3. Diagnostica, 2009.
55(4): p. 223-233.
105. Stovner, L., et al., The global burden of headache: a documentation of headache
prevalence and disability worldwide. Cephalalgia, 2007. 27(3): p. 193-210.
106. Lambert, J., et al., Impact of migraine symptoms on health care use and work
loss in Canada in patients randomly assigned in a phase III clinical trial. Can J Clin
Pharmacol, 2002. 9(3): p. 158-64.
107. Lipton, R.B., W.F. Stewart, and D. Simon, Medical consultation for migraine:
results from the American Migraine Study. Headache, 1998. 38(2): p. 87-96.
108. Holzhammer, J. and C. Wöber, Non-alimentary trigger factors of migraine and
tension-type headache. Schmerz (Berlin, Germany), 2006. 20(3): p. 226.
109. Holzhammer, J. and C. Wöber, [Alimentary trigger factors that provoke migraine
and tension-type headache]. Schmerz (Berlin, Germany), 2006. 20(2): p. 151.
110. Panconesi, A., Alcohol and migraine: trigger factor, consumption, mechanisms. A
review. J Headache Pain, 2008. 9(1): p. 19-27.
111. Spierings, E.L., A.H. Ranke, and P.C. Honkoop, Precipitating and aggravating
factors of migraine versus tension-type headache. Headache, 2001. 41(6): p. 554-
8.
112. Aamodt, A.H., et al., Headache prevalence related to smoking and alcohol use.
The Head-HUNT Study. European Journal of Neurology, 2006. 13(11): p. 1233-
1238.
113. Bigal, M.E., J.N. Liberman, and R.B. Lipton, Obesity and migraine: a population
study. Neurology, 2006. 66(4): p. 545-50.
114. Walters, A., et al., Toward a better definition of the restless legs syndrome.
Movement Disorders, 1995. 10(5): p. 634-642.
115. Garcia-Borreguero, D., et al., Epidemiology of restless legs syndrome: the
current status. Sleep Medicine Reviews, 2006. 10(3): p. 153-167.
116. Von Campenhausen, S., et al., Prevalence and incidence of Parkinson's disease
in Europe. European Neuropsychopharmacology, 2005. 15(4): p. 473-490.
117. Kleinhenz, J., et al., The prevalence of Parkinson disease in West Germany--are
general practice data a suitable survey instrument? Das Offentliche
Gesundheitswesen, 1990. 52(4): p. 181.
118. Schenkman, M., et al., Longitudinal evaluation of economic and physical impact
of Parkinson's disease. Parkinsonism & Related Disorders, 2001. 8(1): p. 41-50.
119. Pritzkuleit, R., F. Beske, and A. Katalinic, [Disease numbers in pneumology - a
projection to 2060]. Pneumologie, 2010. 64(9): p. 535-40.
120. Sullivan, S.D., S.D. Ramsey, and T.A. Lee, The Economic Burden of COPD*.
Chest, 2000. 117(2 suppl): p. 5S.
C.3